1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Pro-inflammatory markers and fatigue in patients with depression: A case-control study, 2020, Pedraz-Petrozzi et al

Discussion in 'Other health news and research' started by Dolphin, Jun 16, 2020.

  1. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    5,097
    Free full text:
    https://www.nature.com/articles/s41598-020-66532-6

     
    Hutan, Esther12, Kitty and 4 others like this.
  2. Woolie

    Woolie Senior Member

    Messages:
    2,918
    I had a look at this, thought it was fairly unexciting. Small sample size, straight-down-the-line division between "depressed" and "control" patients, and then throwing at lot of measures at the analysis so you can be sure something sticks. And then at the end, getting confused about whether you're actually studying depression or fatigue.

    Seems to be moving us backwards not forwards. A few years ago, there were some pretty good studies showing that high levels of inflammatory markers like CRP, TNF-alpha and IL-6 were only reliably associated with certain symptoms of depression - specifically, the "somatic" ones that include things like low energy levels, fatigue, poor sleep, etc. Yep, the ones that aren't really the depression itself but we've got ourselves so messed up that we treat them as the same as what depression really is about (which is sad mood, loss of interest in life - generally, severe and otherwise inexplicable emotional distress).

    This study is a good example:
     
    Last edited: Jun 18, 2020
    Hutan, Esther12, Snowdrop and 6 others like this.

Share This Page